|
Applying Precision Medicine in BRAF V600E–Mutant Metastatic Colorectal Cancer
STATEMENT OF NEED
Colorectal cancer is the second leading cause of cancer death among men and women in the United States (ACS,2021). An estimated 149,500 new cases are diagnosed annually, and 52,980 people die of the disease (ACS, 2021). When detected and treated early at a localized stage, the 5-year survival rate is 90%. However, because colorectal cancer initially exhibits no symptoms and the use of routine screening is suboptimal, most patients are diagnosed at later stages (ACS, 2021).... |
|
|
Gastroenterology 2022 - LIVE STREAMING
The Comprehensive 2022 Gastroenterology Update
This highly rated Harvard Medical School CME program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians.
Practical, Results-Driven Education
Highlights of the 2022 program include:
• Updated g... |
|
|
Improving the Prognosis for Patients with BRAF-Mutant and/or MSI-H mCRC
Are you current with the latest updates with MSI-H/dMMR and/or BRAF-mutant metastatic colorectal cancer? In this case-based activity, leading expert and researcher, Dr. Dung Le discusses the latest approvals and recommendations for patients with MSI-H/dMMR and/or BRAF-mutant mCRC. This activity also features interactive case presentations which involve biomarker testing, treatment selection, and mitigating potential adverse events. |
|
|
Podcast: Applying Precision Medicine in BRAF V600E–Mutant Metastatic Colorectal Cancer
STATEMENT OF NEED
Colorectal cancer is the second leading cause of cancer death among men and women in the United States (ACS,2021). An estimated 149,500 new cases are diagnosed annually, and 52,980 people die of the disease (ACS, 2021). When detected and treated early at a localized stage, the 5-year survival rate is 90%. However, because colorectal cancer initially exhibits no symptoms and the use of routine screening is suboptimal, most patients are diagnosed at later stages (ACS, 2021).... |
|
|
Understanding the Unique Role of HER3 in Oncogenesis
Program Overview
This activity will explore the clinical evidence surrounding the role of HER3 in various tumor types.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Recognize the role of the HER family, and particularly HER3, in oncogenesis
Identify the common causes of disease progression in patients with advanced NSCLC, metastatic breast, colorectal, and other cancers, focusing specifically on treatment failure to epidermal growth f... |
|
|
A Comprehensive Review of Metastatic Colorectal Cancer (mCRC) Management: An Interprofessional Approach to Care
TARGET AUDIENCE:
This activity is designed to meet the educational needs of oncologists, oncology nurses and pharmacists engaged in the care of patients with metastatic colorectal cancer.
PROGRAM OVERVIEW:
This interprofessional activity will cover:
• Changes in treatment combinations and sequencing of regimens, as well as molecular markers that should be tested to guide therapy.
• Supportive care measures and continual monitoring based on their therapy to ensure optimal outcomes an... |
|
|
A Comprehensive Review of Metastatic Colorectal Cancer (mCRC) Management: An Interprofessional Approach to Care
Target Audience
This activity is designed to meet the educational needs of oncologists, oncology nurses and pharmacists engaged in the care of patients with metastatic colorectal cancer.
Program Overview
This activity will address changes in treatment combinations and sequencing of regimens, as well as molecular markers that should be tested to guide therapy. Further, supportive care measures and continual monitoring based on their therapy to ensure optimal outcomes and minimize adverse e... |
|
|
Cleveland Clinic 4th Annual Updates in General Surgery (Streaming Online & USB Drive)
Cleveland Clinic’s 4th Annual Updates in General Surgery provides comprehensive focus on management and treatment options from a general surgical perspective. Complex procedures will be discussed, along with a variety of subjects affecting the rural/community surgeon. A myriad of cases and enhanced recovery protocols will be reviewed covering the wide variety of patients encountered in general surgical practice. Worth 18.5 AMA PRA Category I Credits™, this activity is eligible for America... |
|